Barriers to Treatment Access for Chagas Disease in Mexico

BACKGROUND: According to World Health Organization (WHO) prevalence estimates, 1.1 million people in Mexico are infected with Trypanosoma cruzi, the etiologic agent of Chagas disease (CD). However, limited information is available about access to antitrypanosomal treatment. This study assesses the e...

Descripción completa

Detalles Bibliográficos
Autores principales: Manne, Jennifer M., Snively, Callae S., Ramsey, Janine M., Salgado, Marco Ocampo, Bärnighausen, Till, Reich, Michael R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3798390/
https://www.ncbi.nlm.nih.gov/pubmed/24147169
http://dx.doi.org/10.1371/journal.pntd.0002488

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3798390/
https://www.ncbi.nlm.nih.gov/pubmed/24147169
http://dx.doi.org/10.1371/journal.pntd.0002488

Ejemplares similares